Home > Press > Rice wins award to recruit cancer researcher: $2 million CPRIT grant aims to bring MIT researcher Omid Veiseh to Houston
Omid Veiseh Image courtesy of O. Veiseh |
Abstract:
Rice University has won a $2 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT) to recruit biomaterials researcher and entrepreneur Omid Veiseh to Rice's Department of Bioengineering.
The grant is one of 35 totaling nearly $80 million announced by the publicly funded CPRIT last month.
Veiseh, who just finished a postdoctoral research fellowship in the lab of MIT biomedical engineer Robert Langer, specializes in the development of biomaterials for drug delivery and tissue-engineering applications and is an inventor on 12 pending or awarded patents.
Veiseh said he plans to join Rice's bioengineering faculty in July 2017 and looks forward to establishing his laboratory in the BioScience Research Collaborative.
"I'm looking forward to collaborating with a number of different folks at the Texas Medical Center complex, including people from Baylor College of Medicine, Houston Methodist, the UT Health Science Center at Houston and Texas Children's Hospital," Veiseh said. "Rice is a fantastic institution, and the Department of Bioengineering is highly ranked with world renowned faculty and outstanding students. Those things and the proximity to the Texas Medical Center were a very attractive combination."
Veiseh said he will spend the next year working at Sigilon Inc., a biomaterials startup he co-founded in Cambridge, Mass.
"We have a platform technology that allows us to modulate immune responses to implanted materials," he said. "There's a wide array of applications that we can tackle, from implantable devices to cell-based therapies and regenerative medicine. It's fairly early stage, and that is why I needed a year to focus on it before I start my own lab."
Veiseh said his laboratory will specialize in developing next-generation biomaterials for cancer, regenerative medicine and other applications.
"The goal is to develop technologies that can have a meaningful impact on human health," he said. "The focus will be on developing materials, and there will be a synthetic biology component. The materials will allow us to localize therapies to various parts of the body. They're carriers for drugs, but they can also carry imaging agents that are accessible by MRI, such as magnetic nanoparticles, or imaging agents that are detectable through fluorescence imaging."
He said one area of concentration will be on understanding the pathology of diseases such as cancer to identify targets that are reliable, prognostic indicators. "The engineering aspect will focus on facilitating interaction with those targets through the use of proteins, peptides, antibodies or small molecules," he said.
Prior to joining MIT in 2011, Veiseh earned a bachelor's degree in cell biology at Western Washington University and a dual Ph.D. in materials science and engineering and in nanotechnology from the University of Washington.
In late May, CPRIT awarded six research grants to support the recruitment of promising emerging cancer scientists to academic institutions in Texas. To date, CPRIT has awarded 1,033 grants totaling more than $1.57 billion. The agency was launched in 2009 after Texas voters overwhelmingly approved a 2007 bond issue committing $3 billion to the fight against cancer.
####
About Rice University
Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 3,910 undergraduates and 2,809 graduate students, Rice’s undergraduate student-to-faculty ratio is 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for best quality of life and for lots of race/class interaction by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger’s Personal Finance. To read “What they’re saying about Rice,” go to tinyurl.com/RiceUniversityoverview.
Follow Rice News and Media Relations on Twitter @RiceUNews.
For more information, please click here
Contacts:
Jade Boyd
713-348-6778
Copyright © Rice University
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Cancer
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Atomic force microscopy in 3D July 5th, 2024
Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||